mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |